A new test using gut bacteria to assess prostate cancer risk
TOPIC NUMBER: 458 SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE IONCOBIOMIX: MICROBIOME-BASED TEST FOR PROSTATE CANCER RISK
This study is looking at how the bacteria in your gut might help us better understand your risk of prostate cancer, and if you join, you could help create a new test that could catch prostate cancer earlier and reduce the need for extra procedures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oncobiomix INC. NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11195264 on NIH RePORTER |
What this research studies
This research investigates a novel approach to assess the risk of prostate cancer by analyzing the gut microbiome. It aims to develop a microbiome signature score that evaluates specific gut bacteria associated with prostate cancer, providing a more accurate risk assessment compared to traditional PSA testing. The study will establish a standard operating procedure for this microbiome test, facilitating its clinical validation and potential commercialization. Patients participating in this research may contribute to the development of a tool that could improve early detection of prostate cancer while reducing unnecessary procedures.
Who could benefit from this research
Good fit: Ideal candidates for this research are men at risk for prostate cancer or those undergoing prostate cancer screening.
Not a fit: Patients who have already been diagnosed with advanced prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more accurate and less invasive method for assessing prostate cancer risk.
How similar studies have performed: Other research has shown promise in using microbiome analysis for cancer risk assessment, indicating potential success for this novel approach.
Where this research is happening
San Antonio, United States
- Oncobiomix INC. — San Antonio, United States (Active)
Researchers
- Principal investigator: Leach, Charles — Oncobiomix INC.
- Study coordinator: Leach, Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.